| Primary |
| Multiple Sclerosis |
50.8% |
| Acute Myeloid Leukaemia |
21.0% |
| Product Used For Unknown Indication |
8.7% |
| Prostate Cancer |
4.5% |
| Acute Myeloid Leukaemia Recurrent |
3.2% |
| Secondary Progressive Multiple Sclerosis |
2.8% |
| Prostate Cancer Metastatic |
1.6% |
| Relapsing-remitting Multiple Sclerosis |
1.3% |
| Acute Lymphocytic Leukaemia |
0.8% |
| Bronchopulmonary Aspergillosis |
0.7% |
| Acute Myelomonocytic Leukaemia |
0.6% |
| Hypertension |
0.6% |
| Acute Promyelocytic Leukaemia |
0.5% |
| Off Label Use |
0.5% |
| Blood Cholesterol Increased |
0.4% |
| Non-hodgkin's Lymphoma |
0.4% |
| B-cell Lymphoma |
0.4% |
| Neuralgia |
0.4% |
| Non-hodgkin's Lymphoma Recurrent |
0.4% |
| Thyroid Disorder |
0.4% |
|
| Ejection Fraction Decreased |
15.0% |
| Acute Leukaemia |
13.7% |
| White Blood Cell Count Decreased |
11.7% |
| Leukaemia |
7.1% |
| Acute Promyelocytic Leukaemia |
6.9% |
| Myocardial Infarction |
5.2% |
| Acute Myeloid Leukaemia |
4.6% |
| Septic Shock |
3.5% |
| Cardiac Disorder |
3.3% |
| Cardiomyopathy |
3.1% |
| Sepsis |
3.1% |
| Cardiac Failure |
2.9% |
| Febrile Neutropenia |
2.9% |
| Stomatitis |
2.7% |
| Urinary Tract Infection |
2.7% |
| Vomiting |
2.7% |
| Cardiac Failure Congestive |
2.5% |
| Weight Increased |
2.5% |
| Pyrexia |
2.1% |
| Pneumonia |
1.9% |
|
| Secondary |
| Multiple Sclerosis |
19.6% |
| Acute Myeloid Leukaemia |
12.4% |
| Prophylaxis |
11.6% |
| B-cell Lymphoma |
8.6% |
| Product Used For Unknown Indication |
7.7% |
| Acute Myeloid Leukaemia Recurrent |
6.3% |
| Drug Use For Unknown Indication |
5.0% |
| Non-hodgkin's Lymphoma |
3.2% |
| Bronchopulmonary Aspergillosis |
3.0% |
| Follicle Centre Lymphoma, Follicular Grade I, Ii, Iii Stage Iv |
3.0% |
| Mantle Cell Lymphoma |
2.8% |
| Prophylaxis Of Nausea And Vomiting |
2.6% |
| Pain |
2.2% |
| Langerhans' Cell Granulomatosis |
2.1% |
| Prostate Cancer |
2.1% |
| Bone Pain |
2.0% |
| Prostate Cancer Metastatic |
1.9% |
| Acute Lymphocytic Leukaemia |
1.6% |
| Diabetes Mellitus |
1.2% |
| Leukaemia Recurrent |
1.2% |
|
| White Blood Cell Count Decreased |
10.0% |
| Ejection Fraction Decreased |
7.6% |
| Myocardial Infarction |
7.1% |
| Sepsis |
7.1% |
| Platelet Count Decreased |
6.5% |
| Myelodysplastic Syndrome |
5.3% |
| Pancreatitis Acute |
5.3% |
| Oedema Peripheral |
4.7% |
| Pneumonia |
4.7% |
| Rash |
4.7% |
| Upper Respiratory Tract Infection |
4.7% |
| Febrile Neutropenia |
4.1% |
| Pancreatic Carcinoma |
4.1% |
| Acute Promyelocytic Leukaemia |
3.5% |
| Bronchopulmonary Aspergillosis |
3.5% |
| Pyrexia |
3.5% |
| Urine Output Decreased |
3.5% |
| Ventricular Fibrillation |
3.5% |
| Vision Blurred |
3.5% |
| Infection |
2.9% |
|
| Concomitant |
| Multiple Sclerosis |
29.4% |
| Acute Myeloid Leukaemia |
7.7% |
| Product Used For Unknown Indication |
7.7% |
| Prophylaxis |
7.7% |
| B-cell Lymphoma |
6.1% |
| Metastases To Bone |
5.5% |
| Drug Use For Unknown Indication |
5.3% |
| Non-hodgkin's Lymphoma |
5.0% |
| Chronic Myeloid Leukaemia |
2.9% |
| Stem Cell Transplant |
2.6% |
| Autoimmune Thyroiditis |
2.4% |
| Breast Cancer |
2.4% |
| Anxiety |
2.1% |
| Relapsing-remitting Multiple Sclerosis |
2.1% |
| Prostate Cancer |
2.0% |
| Acute Myeloid Leukaemia Recurrent |
1.9% |
| Antifungal Prophylaxis |
1.9% |
| Mantle Cell Lymphoma |
1.9% |
| Mantle Cell Lymphoma Stage Iv |
1.9% |
| Acute Promyelocytic Leukaemia |
1.7% |
|
| White Blood Cell Count Decreased |
25.3% |
| Death |
6.8% |
| Febrile Neutropenia |
6.2% |
| Hepatomegaly |
4.8% |
| Pyrexia |
4.8% |
| Sepsis |
4.8% |
| Thrombosis |
4.1% |
| Trismus |
4.1% |
| Urinary Tract Infection |
4.1% |
| Vomiting |
4.1% |
| Weight Increased |
4.1% |
| Wound Debridement |
4.1% |
| Idiopathic Thrombocytopenic Purpura |
3.4% |
| Myocardial Infarction |
3.4% |
| Multiple Sclerosis Relapse |
2.7% |
| Platelet Count Decreased |
2.7% |
| Pleural Effusion |
2.7% |
| Thrombocytopenia |
2.7% |
| Vertebral Foraminal Stenosis |
2.7% |
| Headache |
2.1% |
|
